![PDF] Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers | Semantic Scholar PDF] Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/96108724a8ff4b93eb625287258a2a6a67a332cc/4-Table2-1.png)
PDF] Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers | Semantic Scholar
![Maximum recommended dose of statins when associated with immunosuppressant | Download Scientific Diagram Maximum recommended dose of statins when associated with immunosuppressant | Download Scientific Diagram](https://www.researchgate.net/profile/Marcello-Bertoluci/publication/345708545/figure/tbl2/AS:956523706589184@1605064431425/Maximum-recommended-dose-of-statins-when-associated-with-immunosuppressant.png)
Maximum recommended dose of statins when associated with immunosuppressant | Download Scientific Diagram
Tratamiento farmacológico de la dislipemia en pacientes de alto y muy alto riesgo cardiovascular | Pascual-Fuster | Revista Española de Sanidad Penitenciaria
![The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. | Semantic Scholar The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a44b00920637a02af3822dc74d3fea361066e226/3-Table1-1.png)
The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. | Semantic Scholar
![High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better - Mayo Clinic Proceedings High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better - Mayo Clinic Proceedings](http://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/99073c92-32cd-40e3-94ff-311c2dced337/gr1.jpg)
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better - Mayo Clinic Proceedings
![Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort | Circulation: Genomic and Precision Medicine Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort | Circulation: Genomic and Precision Medicine](https://www.ahajournals.org/cms/asset/aa1bd117-9eb4-4eeb-9c16-c7bd350c96d3/e002043fig01.gif)